Log inSign up
AAOIFI No. 21 screening

Is GSK halal?

GSK plc

Halal

GSK plc passed every check under AAOIFI Shariah standard No. 21: no prohibited business activity, and all three financial ratios are within limits.

Checked: 15 October 2026

Exchange

NYSE

Price

49.51

Day

+1.00%

Market cap

$98.49B

Industry

Drug Manufacturers - General

Sector

Healthcare

What the company does

GSK (UK) makes medicines and vaccines: Shingrix (shingles), Arexvy (RSV), HIV drugs (ViiV), asthma and oncology. The consumer unit Haleon was spun off in 2022; its money comes from prescription-drug and vaccine sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $24.19B ÷ 36-month average market cap (estimated) $86.37B = 28.0%

    28.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $5.17B ÷ 36-month average market cap (estimated) $86.37B = 6.0%

    6.0%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $74.28M ÷ annual revenue $43.33B (2025) = 0.2%

    0.2%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $98.49B.

In the lists

In the S&P 500
Not in the S&P 500
Among halal stocks
0.14% · #92 of 1455
Held by funds
SPWO 0.46%

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 6 superinvestors · Average reported price: $52.42

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Drug Manufacturers - General — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyGSK's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →